Inhibition of PAR2 or Wnt/β-catenin Signaling Attenuates Airway Inflammation and Epithelial Barrier Dysfunction in Cigarette Smoke–Induced COPD Models
Current Molecular Pharmacology · 2026-10
DOI: 10.1016/j.cmp.2026.10.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026-10. Verfasst von Chaofan Fan und 18 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Fan, C., Zhang, J., Li, J., Liu, J., Gao, Y., Wang, X., Huang, L., Fan, L., Zhong, K., Gao, Y., Ye, T., Fang, N., Shi, W., Sun, H., Li, K., Jiang, M., Chai, J., Wang, K., & Chen, X. (2026). Inhibition of PAR2 or Wnt/β-catenin Signaling Attenuates Airway Inflammation and Epithelial Barrier Dysfunction in Cigarette Smoke–Induced COPD Models. Current Molecular Pharmacology. https://doi.org/10.1016/j.cmp.2026.10.002
Vancouver
Fan C, Zhang J, Li J, Liu J, Gao Y, Wang X, et al. Inhibition of PAR2 or Wnt/β-catenin Signaling Attenuates Airway Inflammation and Epithelial Barrier Dysfunction in Cigarette Smoke–Induced COPD Models. Current Molecular Pharmacology. 2026. doi:10.1016/j.cmp.2026.10.002
BibTeX
@article{Fan2026,
author = {Fan, Chaofan and Zhang, Jingyi and Li, Jiehong and Liu, Junfang and Gao, Yihan and Wang, Xilong and Huang, Linhui and Fan, Lixia and Zhong, Kai and Gao, Yuxin and Ye, Tiaofei and Fang, Nianxin and Shi, Wenjie and Sun, Hao and Li, Kailai and Jiang, Mengna and Chai, Jinwei and Wang, Kai and Chen, Xin},
title = {Inhibition of PAR2 or Wnt/β-catenin Signaling Attenuates Airway Inflammation and Epithelial Barrier Dysfunction in Cigarette Smoke–Induced COPD Models},
journal = {Current Molecular Pharmacology},
year = {2026},
doi = {10.1016/j.cmp.2026.10.002}
}
EUVIMED